Client was a leader in electronic medical record indexing, working with major hospital systems to ensure continuity of care. With the implementation of new interoperability rules, it was imperative for the company to develop strategic growth options in adjacent markets. Client required consulting support to provide expertise outside of the hospital segment.

AI is reshaping healthcare data, decision support, and drug discovery. The client was a  dominant player in clinical decision support and ePrescribing but faced rising competition from AI-driven startups entering adjacent spaces. Leadership needed a clear picture of where AI posed threats, where it opened opportunity, and how to realign strategy for sustainable growth.

Conducted U.S. market assessment and reimbursement strategy for an imaging innovator pre-FDA clearance, helping position the company for regulatory approval and successful U.S. market entry.

Medication errors cause tens of thousands of deaths annually in the U.S. Existing alert systems produce too many false positives, leading to clinician fatigue and ignored warnings. The client developed an AI-driven platform that sharply improved accuracy but needed a business case and integration strategy? to navigate complex healthcare incentives and prove value to hospitals and payers.

The client built an open-source marketplace connecting healthcare developers, researchers, and organizations to share and deploy data-driven applications. With hundreds of contributors and growing traction among developers, the company needed to convert community enthusiasm into enterprise demand among health systems, life-sciences firms, and payers. Leadership sought a scale-up strategy to attract institutional users and prepare for Series A fundraising.

New interoperability rules threatened to erode demand for the client’s core hospital indexing product. Leadership needed to gauge how much risk the regulation posed and to identify growth paths beyond hospitals.

A potential acquisition in chronic care management and remote monitoring showed promise but came with reimbursement and policy risk. The investor needed clarity on sustainability and growth levers before bidding.

A company that provided mobile vision centers for office workers switched to supporting clinical trials during the pandemic. With normalcy returning, the company needed help to decide whether to invest in building a clinical trials business for the long term.

A leading retailer had decided to enter the healthcare space, with a focus on in-person clinics and other physical assets. The Client’s innovation group sought support to develop and prioritize complementary digital offerings.

A remote patient monitoring (RPM) company that marketed to physician offices wanted to accelerate its growth by adding a consumer pay offering. Health Business Group conducted consumer market research, identified partnership opportunities, and developed a go to market plan.